Conversion from Tacrolimus to Sirolimus May Increase the Risk of Cardiovascular Events in Kidney Transplant Recipients.

被引:0
|
作者
Kim, M. [1 ]
Pavlakis, M. [1 ]
Rogers, C. [1 ]
机构
[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:184 / 184
页数:1
相关论文
共 50 条
  • [1] Cardiovascular risk profile before and after tacrolimus conversion in kidney transplant recipients.
    Luan, Fu L.
    Miles, Clifford D.
    Blosser, Christopher
    Cibrik, Diane M.
    Norman, Silas
    Chopra, Pavan
    Ojo, Akinlolu A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 534 - 534
  • [2] Conversion from Tacrolimus to Sirolimus-Based Immunosuppressive Regimen in Kidney Transplant Recipients. Preliminary Results
    Medina-Pestana, J. O.
    Garcia, V. D.
    David-Neto, E.
    Carvalho, D. B. M.
    Contieri, F. L.
    Abbud-Filho, M.
    Tedesco-Silva, H.
    Ikehara, E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 462 - 462
  • [3] Conversion of Tacrolimus Immediate Release to LCP Tacrolimus in Obese Kidney Transplant Recipients.
    Newman, J.
    Patel, N.
    Patel, S.
    Sprague, T.
    Andrade, E.
    Rao, N.
    Bartlett, F.
    Dubay, D.
    Rohan, V.
    Casey, M.
    Taber, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 564 - 564
  • [4] Estimation of a Tacrolimus to Sirolimus Dose Conversion Ratio in Kidney Transplant Recipients
    Kim, M.
    Mandelbrot, D.
    Rogers, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 303 - 304
  • [5] Evaluation of the Conversion from Tacrolimus to Sirolimus in Liver Transplant Recipients
    Bakhtiari, H.
    Todd, S.
    Snyder, H.
    Lo, D.
    Flynn, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 759 - 759
  • [6] Effect of conversion from cyclosporine A (CSA) to tacrolimus (FK 506) on cardiovascular risk factors in liver transplant recipients.
    Canzanello, VJ
    Schwartz, LL
    Taler, SJ
    Textor, SC
    Atwood, G
    Porayko, MK
    Wiesner, RH
    Krom, RAF
    HEPATOLOGY, 1997, 26 (04) : 1443 - 1443
  • [7] Impact of Induction Therapy on Cardiovascular Events in Kidney Transplant Recipients.
    Sandal, S.
    Bae, S.
    Massie, A.
    Cantarovich, M.
    Segev, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 208 - 209
  • [8] The Sirolimus Era: Infections in kidney transplant recipients.
    Lattes, R
    del Carmen Rial, M
    Radisic, M
    Ryb, M
    Escudero, P
    Casadei, D
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 353 - 354
  • [9] Improved renal function after conversion from tacrolimus/sirolimus to tacrolimus/mycophenolate mofetil in kidney transplant recipients
    Augustine, JJ
    Chang, PC
    Knauss, TC
    Aeder, MI
    Bodziak, KA
    Schulak, JA
    Hricik, DE
    TRANSPLANTATION, 2006, 81 (07) : 1004 - 1009
  • [10] CONVERSION FROM SIROLIMUS TO EVEROLIMUS IN KIDNEY TRANSPLANT RECIPIENTS
    Coentrao, Luis
    Carvalho, Catarina
    Sampaio, Susana
    Santos, Joana
    Bustorff, Manuela
    Oliveira, Jose G.
    Pestana, Manuel
    TRANSPLANT INTERNATIONAL, 2009, 22 : 233 - 233